Eris Lifesciences working on $200m IPO plans, ChrysCapital may exit

Eris Lifesciences Pvt. Ltd has hired three investment banks to manage its initial share sale, offering private equity investor ChrysCapital an opportunity to sell its entire stake in the drug maker, three people aware of the development said.